Summary
This prediction ended on 10.03.22 with a price of €18.74. The prediction had a final performance of 25.18%. A total of €1.29 was paid as dividends for this prediction. Snowman has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| GSK plc | 2.756% | 2.756% | 14.956% | 22.293% |
| iShares Core DAX® | 2.112% | -0.367% | 13.466% | 16.854% |
| iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% | 42.934% |
| iShares Nikkei 225® | -1.555% | -7.320% | 18.451% | 2.941% |
| iShares S&P 500 | -0.472% | -2.078% | 27.488% | 41.955% |
According to Snowman what are the pros and cons of GSK plc for the foreseeable future?
Pros
High dividend yield expected
Good rating
Very small cyclical dependencies
Fair valuation
Medium risks for its business
Market Leader or Top 3
Some uniques
Well known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Cons
Comments by Snowman for this prediction
In the thread GlaxoSmithKline plc diskutieren
Kursziel geändert auf 22,0
In the thread Trading GlaxoSmithKline plc
Die von Snowman gewählte maximale Laufzeit wurde überschritten